Next Generation of mRNA Vaccinology: This landscape-changing technology has the potential to be used to manage some of healthcare’s most challenging diseases quickly and efficiently.
Advancements in the generation, purification, and cellular delivery of RNA have enabled the development of mRNA vaccines across a broad array of applications, such as cancer and Zika virus infection. The technology is cost-effective, relatively simple to manufacture, and elicits immunity in a novel way. Furthermore, the emergence of the COVID-19 pandemic demonstrated that the world needed rapid development of a vaccine that was deployable around the globe. Because of previous research that laid the groundwork for this technology, an effective COVID-19 vaccine was developed, produced, approved, and deployed in less than a year. This landscape-changing technology has the potential to be used to manage some of healthcare’s most challenging diseases quickly and efficiently.
Latest from Today's Medical Developments
- #70 Manufacturing Matters - CUI Crash Course with Smithers
- Precision matters
- Talking toolholding and workholding over lunch
- How accurate strength predictions will shape the future of lightweight materials
- Unpacking electric vehicle market turbulence
- TRANSOR launches new website
- Guill Tool & Engineering’s micro medical extrusion tooling
- BD announces $35 million investment in syringe manufacturing
